Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2028)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Asthma and COPD Drug Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Asthma and COPD Drug Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Asthma and COPD Drug Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Asthma and COPD Drug Market-Segmentation by Type
5.1 Bronchodilators
5.2 Anti-inflammatory Drugs
5.3 Monoclonal Antibodies
5.4 Combination Drugs
6 Global Asthma and COPD Drug Market-Segmentation by Application
6.1 Asthma
6.2 COPD
7 Global Asthma and COPD Drug Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence - Company Profiles
8.1 Merck and Co
8.1.1 Merck and Co Profile
8.1.2 Merck and Co Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Merck and Co Product/Solution Launches and Enhancements Analysis
8.1.4 Merck and Co Business Overview/Recent Development/Acquisitions
8.2 AstraZeneca
8.2.1 AstraZeneca Profile
8.2.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 AstraZeneca Product/Solution Launches and Enhancements Analysis
8.2.4 AstraZeneca Business Overview/Recent Development/Acquisitions
8.3 F. Hoffmann-La Roche
8.3.1 F. Hoffmann-La Roche Profile
8.3.2 F. Hoffmann-La Roche Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 F. Hoffmann-La Roche Product/Solution Launches and Enhancements Analysis
8.3.4 F. Hoffmann-La Roche Business Overview/Recent Development/Acquisitions
8.4 Boehringer Ingelheim
8.4.1 Boehringer Ingelheim Profile
8.4.2 Boehringer Ingelheim Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Boehringer Ingelheim Product/Solution Launches and Enhancements Analysis
8.4.4 Boehringer Ingelheim Business Overview/Recent Development/Acquisitions
8.5 Novartis AG
8.5.1 Novartis AG Profile
8.5.2 Novartis AG Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 Novartis AG Product/Solution Launches and Enhancements Analysis
8.5.4 Novartis AG Business Overview/Recent Development/Acquisitions
8.6 GlaxoSmithKline
8.6.1 GlaxoSmithKline Profile
8.6.2 GlaxoSmithKline Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 GlaxoSmithKline Product/Solution Launches and Enhancements Analysis
8.6.4 GlaxoSmithKline Business Overview/Recent Development/Acquisitions
9 Global Asthma and COPD Drug Market-Segmentation by Geography
10 North America
10.1 North America Asthma and COPD Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Asthma and COPD Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Asthma and COPD Drug Production Analysis from 2015-2020
10.4 North America Asthma and COPD Drug Consumption Analysis from 2015-2020
10.5 North America Asthma and COPD Drug Import and Export from 2015-2020
10.6 North America Asthma and COPD Drug Value, Production and Market Share by Type (2015-2020)
10.7 North America Asthma and COPD Drug Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Asthma and COPD Drug by Country (United States, Canada)
10.8.1 North America Asthma and COPD Drug Sales by Country (2015-2020)
10.8.2 North America Asthma and COPD Drug Consumption Value by Country (2015-2020)
10.9 North America Asthma and COPD Drug Market PEST Analysis
11 Europe
11.1 Europe Asthma and COPD Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Asthma and COPD Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Asthma and COPD Drug Production Analysis from 2015-2020
11.4 Europe Asthma and COPD Drug Consumption Analysis from 2015-2020
11.5 Europe Asthma and COPD Drug Import and Export from 2015-2020
11.6 Europe Asthma and COPD Drug Value, Production and Market Share by Type (2015-2020)
11.7 Europe Asthma and COPD Drug Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Asthma and COPD Drug by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Asthma and COPD Drug Sales by Country (2015-2020)
11.8.2 Europe Asthma and COPD Drug Consumption Value by Country (2015-2020)
11.9 Europe Asthma and COPD Drug Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Asthma and COPD Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Asthma and COPD Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Asthma and COPD Drug Production Analysis from 2015-2020
12.4 Asia-Pacific Asthma and COPD Drug Consumption Analysis from 2015-2020
12.5 Asia-Pacific Asthma and COPD Drug Import and Export from 2015-2020
12.6 Asia-Pacific Asthma and COPD Drug Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Asthma and COPD Drug Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Asthma and COPD Drug by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Asthma and COPD Drug Sales by Country (2015-2020)
12.8.2 Asia-Pacific Asthma and COPD Drug Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Asthma and COPD Drug Market PEST Analysis
13 Latin America
13.1 Latin America Asthma and COPD Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Asthma and COPD Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Asthma and COPD Drug Production Analysis from 2015-2020
13.4 Latin America Asthma and COPD Drug Consumption Analysis from 2015-2020
13.5 Latin America Asthma and COPD Drug Import and Export from 2015-2020
13.6 Latin America Asthma and COPD Drug Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Asthma and COPD Drug Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Asthma and COPD Drug by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Asthma and COPD Drug Sales by Country (2015-2020)
13.8.2 Latin America Asthma and COPD Drug Consumption Value by Country (2015-2020)
13.9 Latin America Asthma and COPD Drug Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Asthma and COPD Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Asthma and COPD Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Asthma and COPD Drug Production Analysis from 2015-2020
14.4 Middle East & Africa Asthma and COPD Drug Consumption Analysis from 2015-2020
14.5 Middle East & Africa Asthma and COPD Drug Import and Export from 2015-2020
14.6 Middle East & Africa Asthma and COPD Drug Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Asthma and COPD Drug Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Asthma and COPD Drug by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Asthma and COPD Drug Sales by Country (2015-2020)
14.8.2 Middle East & Africa Asthma and COPD Drug Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Asthma and COPD Drug Market PEST Analysis
15 Future Forecast of the Global Asthma and COPD Drug Market from 2020-2028
15.1 Future Forecast of the Global Asthma and COPD Drug Market from 2020-2028 Segment by Region
15.2 Global Asthma and COPD Drug Production and Growth Rate Forecast by Type (2020-2028)
15.3 Global Asthma and COPD Drug Consumption and Growth Rate Forecast by Application (2020-2028)
16 Appendix
16.1 Methodology
16.2 Research Data Source
